Nanoparticles in gene-editing therapy may correct CF defects
Optimizing nanoparticles, mucus-clearing treatment made therapy more efficient by Steve Bryson, PhD | September 9, 2025 Researchers have...
A huge turning point: CF medicine’s Trikafta/Kaftrio added to WHO Essential Medicines List
Today marks a historic breakthrough in the fight for global access to lifesaving cystic fibrosis (CF) treatment. The World Health...
Lipidome profile of Cystic Fibrosis Related Diabetes, Type 1 and Type 2 Diabetes Mellitus: potential links to inflammation and glucose and lipid metabolism.
Alessandra Mingione, Cristian Loretelli, Michele Dei Cas, Francesca Pivari, Matteo Barcella, Ivan Merelli, Aida Zulueta, Rita Paroni,...
CFTR profiles and phenotypic associations in Pakistani children and adults with suspected cystic fibrosis
Javeria Aijaz, Zaira Rehman, Saima Ali, Saba Shahid, Ali Akbar, Muhammad Fareeduddin* For detailed information, please click and download...
Trial tests new approach with CFTR modulators for cystic fibrosis
First participants dosed in Phase 1 study of drug combination The first participants have been dosed in a clinical trial that’s testing...
Change in pulmonary pathogens three years after elexacaftor/tezacaftor/ivacaftor: an observational study in the Danish cystic fibrosis cohort
Maria Pals Bendixen 1 ∗ , Majbritt Jeppesen 2 ∗ , Oihane Irazoki 1 3 , Camilla Bjørn Jensen 4 , Mikala Wang 5 , Janne Petersen 4 6 ,...
Cystic Fibrosis Foundation Commits Up to an Additional $24 Million for Prime Medicine to Develop Gene Editing Therapy
The funding will support preclinical research focused on the nonsense mutation G542X BETHESDA, Md. (July 16, 2025) – Today, the Cystic...
Early data from ARCT-032 clinical trial for CF expected next month
Study still recruiting patients not eligible for CFTR modulators and others Interim results from the first nine participants in a Phase 2...
CF lung inflammation persists after treatment due to stubborn bacteria
Study findings challenge idea that damage to respiratory organ is key factor Persistent Pseudomonas aeruginosa infection in people with...
After the earthquake: Unmet needs in people with cystic fibrosis in Turkiye- multicenter study
Author links open overlay panel Seyda Karabulut a , Velat Sen b , Beste Özsezen c , Ali Özdemir d , Melih Hangül e , Suat Savas b ,...
